Allergan. BOTOX® mechanism of action. U.S.A: Botox Medical. 2019. (accessed 21 March 2019)

American Academy of Facial Aesthetics. What is Bruxism. 2019. (accesed 21 March 2019)

Asutay F, Atalay Y, Asutay H, Acar AH. The evaluation of the clinical effects of botulinum toxin on nocturnal bruxism. Pain Research and Management. 2017; 2017:1-5

British National Formulary. Botulinum Toxin Type A: Indications. 2019a. (accessed 21 March 2019)

British National Formulary. Botulinum Toxin Type A: Interactions. 2019. (accessed 21 March 2019)

The Bruxism Association. Causes of bruxism. 2019. (accessed 21 March 2019)

Facial rejuvenation: Off licence applications for botulinum toxin. 2015. (accessed 21 March 2019)

De Boulle K, Heydenrych I. Patient factors influencing dermal filler complications: prevention, assessment, and treatment. Clinical, Cosmetic and Investigational Dermatology. 2015; 205

Department of Health and Social Care. Review of the Regulation of Cosmetic Interventions. 2013. (accessed 21 March 2019)

Deschamps-Braly. Revision of masseter muscle reduction using Botox® and Dysport®. 2019. (accessed 21 March 2019)

Houses of Parliament. POSTNOTE 444. Cosmetic procedures. 2013. (accessed 21 March 2019)

Botox for bruxism: learn what's right for you. 2019. (accessed 21 March 2019)

NHS. Overview: Teeth Grinding (Bruxism. 2017a. (accessed 21 March 2019)

NHS. Treatment: Teeth Grinding (Bruxism). 2017b. (accessed 21 March 2019)

Botulism. BMJ Best Practice. 2019. (accessed 21 March 2019)

Nigam PK, Nigam A. Botulinum toxin. Indian J Dermatol. 2010; 55:(1)8-14

Peng H-LP, Peng J-H. Complications of botulinum toxin injection for masseter hypertrophy: Incidence rate from 2036 treatments and summary of causes and preventions. Journal of Cosmetic Dermatology. 2018; 17:(1)33-38

Royal Pharmaceutical Society. A competency framework for all prescribers. 2016. (accessed 21 March 2019)

Botox: the drug that's treating everything. TIME Magazine. 2017. (accessed 21 March 2019)

Treating the effects of bruxism with botulinum toxin. MDedge Dermatology. 2018. (accessed 22 March 2019)

Tan EK, Jankovic J. Treating severe bruxism with botulinum toxin. J Am Dent Assoc. 2000; 131:(2)211-216

World Health Organisation. Botulism. 2018. (accessed 21 March 2019)

Yiannakopoulou E. Serious and Long-Term Adverse Events Associated with the Therapeutic and Cosmetic Use of Botulinum Toxin. Pharmacology. 2015; 95:65-69

Treating the effects of bruxism with botulinum toxin type A: an overview

02 April 2019
Volume 8 · Issue 3


This article aims to establish the effectiveness of Botulinum Toxin Type A (BoNTA) in treating the effects of bruxism in adults. It will also establish the necessity for treating patients holistically and the requirements for practitioners who do offer, or are thinking of offering, this treatment to have a thorough and sound understanding of several key considerations.

This article will also aim to establish best practice guidance for those undertaking the procedure, as well as identify who a suitable candidate for this procedure may be. Side effects and/or contraindications associated with this procedure will also be considered, as well as typical duration for results and the optimal time to retreat.

In a world where many patients are still afraid they will be left looking ‘overdone’ and ‘unable to move their face’ after treatment with botulinum neurotoxin type A (BoNTA), it is perhaps reasonable to suggest that many patients are largely unaware of the vast majority of cosmetic uses that this drug has—let alone the number of therapeutic uses. A 2017 TIME Magazine headline, ‘How Botox became the drug the that's treating everything’, supports the notion that between approved and off-label uses, BoNTA really is ‘a marvel of medicine’ (Sifferlin, 2017).

It is perhaps one thing expecting patients to understand the options available to them when they approach their chosen practitioner for treatment, but it is also worth noting that a significant number of healthcare professionals using BoNTA on a daily basis may be largely unaware of the nature of this procedure—and the results it offers in reality. This article aims to highlight indications for treatment of bruxism using BoNTA to healthcare professionals practising medical aesthetics. This article will also attempt to provide basic guidance on how important a sound understanding of suitable candidates for this procedure are, and what alternative views must be considered when thinking about delivering this treatment.

Register now to continue reading

Thank you for visiting Journal of Aesthetic Nurses and reading some of our peer-reviewed resources for aesthetic nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • New content and clinical newsletter updates each month